← Back to Search

Absorbent Dressing

Mepilex Up Dressing for Chronic Wounds

N/A
Recruiting
Led By Hadar Lev-Tov, MD, MAS
Research Sponsored by Molnlycke Health Care AB
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with a chronic, exuding VLU or DFU
Adult aged ≥18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up a maximum total treatment period of 44 days or until healed, whichever occurs first.
Awards & highlights

Study Summary

This trial will monitor the progress of wounds in people with venous or diabetic ulcers while they use Mepilex Up dressing to see how it helps them heal over time.

Who is the study for?
This trial is for adults over 18 with chronic, oozing wounds from diabetic foot ulcers or venous leg ulcers. Participants should have a wound size between 3 to 30 cm2 and be willing to use compression therapy if needed. They must not have an infected ulcer, allergy to dressing materials, or be in another wound study.Check my eligibility
What is being tested?
The trial tests Mepilex Up, an absorbent dressing on patients with venous leg and diabetic foot ulcers. It aims to track the healing progress of these wounds over up to six weeks or until healed, changing dressings weekly.See study design
What are the potential side effects?
Potential side effects may include skin irritation or allergic reactions due to the materials in Mepilex Up dressing. However, since it's a non-invasive treatment, severe side effects are unlikely.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have a long-lasting, leaking wound from a venous leg ulcer or diabetic foot ulcer.
Select...
I am 18 years old or older.
Select...
I have a long-lasting, leaking wound from a venous leg ulcer or diabetic foot ulcer.
Select...
My wound size fits the specified range for treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~a maximum total treatment period of 44 days or until healed, whichever occurs first.
This trial's timeline: 3 weeks for screening, Varies for treatment, and a maximum total treatment period of 44 days or until healed, whichever occurs first. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Injury wounds
Secondary outcome measures
Change in exudate amount over time
Change in exudate nature over time
Change in granulation tissue over time
+25 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Supportive Care with Mepilex UpExperimental Treatment1 Intervention
All Subjects will use a soft, silicone, non-bordered, adhesive, foam dressing called Mepilex Up as the absorbent primary dressing.

Find a Location

Who is running the clinical trial?

Molnlycke Health Care ABLead Sponsor
54 Previous Clinical Trials
7,757 Total Patients Enrolled
Hadar Lev-Tov, MD, MASPrincipal InvestigatorUniversity of Miami
2 Previous Clinical Trials
129 Total Patients Enrolled

Media Library

Mepilex Up (Absorbent Dressing) Clinical Trial Eligibility Overview. Trial Name: NCT05588583 — N/A
Venous Leg Ulcer Research Study Groups: Supportive Care with Mepilex Up
Venous Leg Ulcer Clinical Trial 2023: Mepilex Up Highlights & Side Effects. Trial Name: NCT05588583 — N/A
Mepilex Up (Absorbent Dressing) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05588583 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the scale of this research investigation?

"Affirmative. According to clinicaltrials.gov, this research protocol is currently recruiting participants; it was posted on October 31st 2022 and revised on November 7th of the same year. The study has room for 68 enrollees between two sites."

Answered by AI

Does this research currently have any room for new participants?

"As per the information available on clinicaltrials.gov, this research is currently recruiting individuals to take part in the trial. This study was publicly uploaded on October 31st 2022 and has since been revised on November 7th of that year."

Answered by AI
~28 spots leftby Apr 2025